Salient Bio is a metagenomics and machine-learning enabled diagnostic and wellness test developer.
Salient Bio has raised $3.2M in total funding. The most recent round was Seed. The last funding was announced in September 2025.
Salient Bio's investors include THENA Capital, Vanneck EIS.
Salient Bio is headquartered in London, United Kingdom.
Salient Bio is a metagenomics and machine-learning enabled diagnostic and wellness test developer.
Salient Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Salient Bio — Funding & Investors." VCBacked, September 3, 2025, https://www.vcbacked.co/company/salient-bio. Accessed October 30, 2026.
VCBacked. (2025). Salient Bio — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/salient-bio
{{cite web |title=Salient Bio — Funding & Investors |url=https://www.vcbacked.co/company/salient-bio |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated